← Back to headlines
Johnson & Johnson reports strong Q1 earnings driven by oncology growth
Johnson & Johnson has reported its first-quarter earnings, setting a positive tone for the season with significant growth in its oncology division.
15 Apr, 11:29 — 15 Apr, 11:29
Sources
Showing 1 of 1 sources
